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  Rising petroleum costs, trade imbalances and environmental concerns have stimulated efforts 
to advance the microbial production of fuels from lignocellulosic biomass. Here we identify a 
novel biosynthetic alternative to D2 diesel fuel, bisabolane, and engineer microbial platforms 
for the production of its immediate precursor, bisabolene. First, we identify bisabolane as an 
alternative to D2 diesel by measuring the fuel properties of chemically hydrogenated commercial 
bisabolene. Then, via a combination of enzyme screening and metabolic engineering, we obtain 
a more than tenfold increase in bisabolene titers in   Escherichia coli   to      >    900   mg   l     −     1 .  We  produce 
bisabolene in  Saccharomyces cerevisiae  (    >    900   mg   l     −     1 ), a widely used platform for the production 
of ethanol. Finally, we chemically hydrogenate biosynthetic bisabolene into bisabolane. This 
work presents a framework for the identiﬁ  cation of novel terpene-based advanced biofuels 
and the rapid engineering of microbial farnesyl diphosphate-overproducing platforms for the 
production  of  biofuels.          
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 E
thanol, the most widely used renewable liquid transporta-
tion fuel  1  , has only 70  %   of the energy content of gasoline and 
its hygroscopicity makes it incompatible with existing fuel, 
storage and distribution infrastructure  2  . Advanced biofuels with 
high-energy content and physicochemical properties similar to 
petroleum-based fuels may be better alternatives, as they would 
allow use of existing engine designs, distribution systems and stor-
age infrastructure  3 .  Th   e challenge lies in identifying and producing 
a biofuel with fuel and physicochemical properties similar to petro-
leum-based fuels. 
  Terpenes, traditionally used as fragrances and fl  avours  4 ,  have  the 
potential to serve as advanced biofuel precursors  5,6  . For example, 
the fully reduced form of the linear terpene farnesene is being pur-
sued as an alternative biosynthetic diesel in the market  7 .  Terpenes 
are biosynthesized from the C  5   universal precursors, isopentenyl 
diphosphate (IPP) and dimethylallyl diphosphate (DMAPP). Pre-
nyltransferases assemble IPP and DMAPP into linear prenyl diphos-
phate precursors, such as farnesyl diphosphate (FPP, C  15  ), which are 
rearranged by terpene synthases into a variety of diff  erent terpenes, 
such as sesquiterpenes (C  15 ). 
  Although plants are the natural source of terpenes, engineered 
microbial platforms may be the most convenient and cost-eff  ective 
approach for large-scale production of terpene-based advanced bio-
fuels  2  . Previously, we engineered the mevalonate pathway in both 
  Escherichia coli   and   Saccharomyces cerevisiae   for overproduction of 
FPP  8,9  . Introduction of a sesquiterpene synthase to these engineered 
organisms has allowed the production of a variety of sesquiterpe-
nes  8 – 10  , albeit not in large enough quantities to serve as biosynthetic 
precursors to advanced biofuels. For example, amorphadiene, a 
key intermediate in the semi-synthesis of the antimalarial drug 
artemisinin, can be produced by introduction of amorphadiene 
synthase that cyclizes FPP. Amorphadiene is currently the most 
highly  produced  sesquiterpene  at   ~ 750   mg   l     −     1   in   S. cerevisiae  11   and 
 ~ 500   mg   l     −     1   in   E. coli  12   in shake fl   asks  and  27   g   l     −     1   in   E. coli ,  using 
fermentors  13 . 
 We propose that the generality of the microbial FPP overproduc-
tion platforms should allow for the biosynthesis of sesquiterpenes 
to serve as advanced biofuel precursors by introduction of a sesquit-
erpene synthase producing the desired compound. Th  e  viability  of 
this strategy hinges on identifying a sesquiterpene biofuel precur-
sor, and a sesquiterpene synthase able to microbially produce the 
desired compound in high titers. Adding to the complexity of this 
proposition is the limited commercial availability of sesquiterpe-
nes to derivatize and test for fuel properties, and the fact that most 
sesquiterpene synthases are of plant origin and thus potentially dif-
fi  cult to express in microbes. 
  Here we report the identifi  cation of a novel biosynthetic alterna-
tive to D2 diesel fuel, bisabolane, and the engineering of microbial 
platforms for the overproduction of its immediate precursor, bisab-
olene (  Fig. 1  ). Hydrogenation of commercially available bisabolene 
led to the identifi  cation of bisabolane as a biosynthetic alternative to 
D2 diesel. Th   en, we engineered microbial platforms to produce bis-
abolene (  1  ), the immediate precursor to bisabolane (  2  ). First, using 
microbial platforms for the overproduction of FPP, we screened 
for sesquiterpene synthases able to convert FPP into bisabolene 
in high titers. Second, we optimized the mevalonate pathway in 
  E. coli   for increased bisabolene production by codon-optimization 
of heterologous pathway genes and introduction of extra promot-
ers to increase expression of key enzymes in the pathway. Th  ird,  we 
produced bisabolene in   S. cerevisiae  , a widely used platform for the 
production of ethanol. Finally, we demonstrated the conversion of 
biosynthetic bisabolene into bisabolane using chemical hydrogena-
tion. To our knowledge, this is the fi  rst report of a reduced mono-
cyclic sesquiterpene, bisabolane, as a biosynthetic alternative to D2 
diesel, and the fi  rst microbial overproduction of bisabolene in  E. coli  
and   S. cerevisiae   at titers over 900     mg     l      −     1   in shake fl  asks.   
 Results  
  Bisabolane as a biosynthetic alternative to D2 diesel fuel   .     We  
hypothesized that a fully reduced monocyclic sesquiterpene, 
bisabolane (  2  ), may serve as a biosynthetic alternative to diesel   
(  Fig. 2  ). D2 diesel, the fuel for compression ignition engines, is a 
mixture of linear, branched, and cyclic alkanes with an average carbon 
length of 16 (  3  ). Among other properties, biosynthetic alternatives 
to D2 diesel should have a similar cetane number and comparable 
cold properties  14  . Bisabolane has a carbon length (C  15 ),  close  to 
the average carbon length of diesel (C  16  ). Further, the branching 
found in the linear portion of bisabolane may result in benefi  cial 
fuel cold properties. Finally, the ring portion of bisabolane increases 
the density of the fuel, which will increase the energy density per 
volume of fuel. To our knowledge, there are no reports of bisabolane 
as a biosynthetic alternative to D2 diesel. 
  To determine whether bisabolane could serve as a biosynthetic 
alternative to D2 diesel, we chemically hydrogenated commercially 
available bisabolene and measured its fuel properties. Bisabolene 
was the major component of commercial bisabolene, which also 
contained impurities such as farnesene (  Fig. 3a  ). Bisabolane was 
the major component of the hydrogenated commercial bisabolene 
representing   ~ 50 %   of  the  product  profi  le, followed by farnesane (  4 ) 
( ~ 20 % ),  partially  hydrogenated  bisabolene  ( ~ 20 % ),  and  aromatized 
bisabolene ( ~ 7 % ) ( Fig. 3b ;  Supplementary Fig. S1 ).  Table 1  shows the 
physicochemical and fuel properties of D2 diesel  15  , biodiesel (  5 ) 15 , 
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  Figure  1     |          Bisabolane  from  chemical  hydrogenation  of  microbially 
produced bisabolene. The engineered microbe (yellow box) converts 
simple sugars into acetyl-CoA   via   primary metabolism. A combination 
of metabolic engineering of the heterologous mevalonate pathway to 
convert acetyl-CoA into FPP and enzyme screening to identify a terpene 
synthase to convert FPP into bisabolene (  1  ) is used to produce bisabolene 
at high titers. Chemical hydrogenation of biosynthetic bisabolene leads to 
bisabolane (  2  ), a biosynthetic alternative to D2 diesel.   
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  Figure  2     |          Chemical  structures  of  fuels. Bisabolane (  2  ); Hexadecane (  3 ),  a 
representative molecule for diesel; farnesane (  4  ); and methyl palmiate (  5 ), 
a representative molecule for fatty acid methyl esters.   ARTICLE   
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and the hydrogenated commercial bisabolene. Th  e hydrogenated 
commercial bisabolene has a cetane number of 41.9, which lies 
within the range of D2 diesel (40  –  55). Further, hydrogenated com-
mercial bisabolene has better cold properties than those of D2 die-
sel,  with  a  cloud  point  of      −    78    ° C  as  compared  with      −    35    ° C,  and  than 
those  of  biodiesel,  which  has  a  cloud  point  of      −    3    ° C.  Commercial  bis-
abolene has a cetane number of 30 and is not a D2 diesel alternative. 
Th  e fuel properties of hydrogenated commercial bisabolene may be 
impacted by the presence of compounds other than bisabolane in the 
fi  nal product. For example, although farnesane may improve some 
of the biofuel characteristics such as cetane number, partially hydro-
genated and aromatized bisabolenes would deteriorate these same 
fuel properties. Further, the linear structure of farnesane results in a 
lower  density  (0.77   g   ml     −     1 )  than  cyclic  bisabolane  (0.88   g   ml     −     1 ).  Given 
the similar ratios of potentially benefi  cial and detrimental byproducts, 
we estimate that their eff  ect on the fuel properties will cancel each 
other out. Th   erefore, the measured cetane number, which is within the 
range of D2 diesel, can be primarily attributed to the major product, 
bisabolane. Taken together, these data demonstrate that bisabolane is a 
biosynthetic alternative to D2 diesel fuel.     
  Screening enzymes for high bisabolene titers in   E. coli     .    Knowing 
that bisabolane is a biosynthetic alternative to D2 diesel, we used 
a previously engineered   E. coli   platform for the overproduction of 
FPP to screen for terpene synthases to convert FPP into a mono-
cyclic sesquiterpene in high titers. Th  e monocyclic sesquiterpene 
could then be chemically hydrogenated to bisabolane. Briefl  y, wild-
type   E. coli   uses the deoxyxylulose 5-phosphate pathway to convert 
pyruvate and glyceraldehyde-3-phosphate to IPP and DMAPP, the 
precursors to all terpenes. Previously, we showed that the native 
deoxyxylulose 5-phosphate pathway in   E. coli   produces  negligible 
amounts of sesquiterpenes when overexpressing a sesquiterpene 
synthase  8  . To increase the production of terpenes, we engineered 
  E. coli   to heterologously express the mevalonate pathway from 
  S. cerevisiae   to overproduce FPP from acetyl-CoA  8  . Recently, the 
eight genes of the heterologous mevalonate pathway were assem-
bled in a single plasmid (pJBEI-2704) to reduce metabolic burden 
and the number of antibiotic markers  12  . To screen for terpene syn-
thases that produce monocyclic sesquiterpenes, we transformed 
  E. coli   with pJBEI-2704 and a plasmid expressing the terpene syn-
thase gene. Terpene synthase screening was necessary, as these 
enzymes have been previously identifi  ed as bottlenecks in micro-
bial sesquiterpene production  16  . In nature, plants produce three 
monocyclic sesquiterpenes that could be chemically hydrogenated 
to bisabolane: curcumene, zingiberene and bisabolene. For biofuel 
purposes, we needed to identify a terpene synthase that produces a 
monocyclic sesquiterpene as its major product. Th   e two known zin-
giberene synthases in the literature  17   produce zingiberene as   ≤ 40 %  
of their product profi  le and were not included in the screen. Th  e  only 
known curcumene synthase in the literature  17  , that from patchouli 
(  Pogostemon cablin ),  produced  curcumene  in   ~ 90 %   of  its  prod-
uct profi  le. Th   erefore, we synthesized the   E. coli   codon-optimized 
  P. cablin   curcumene synthase gene and tested it for curcumene pro-
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     Figure  3     |          Gas  chromatography  analysis  of  commercial  bisabolene  and  hydrogenated  commercial  bisabolene. (  a  ) GC trace of commercial bisabolene. 
Commercial bisabolene (TCI America: bisabolene B1413) has four major peaks (RT: 8.12, 8.22, 8.59 and 8.92). Peak at RT: 8.92 has the same retention 
time as biosynthetic bisabolene (  α  -bisabolene). Peak at RT: 8.12 has the same retention time as a commercial sample of farnesene (Fluka:   β -farnesene 
73492). Peaks at RT: 8.22 and 8.59 are sesquiterpenes based on the m  /  z       =       204. The ratio of bisabolene to farnesene is   ~ 2:1.  ( b  ) GC trace of hydrogenated 
commercial bisabolene. Hydrogenated commercial bisabolene has four main peaks (RT: 7.35, 7.70, 7.98, and 8.08). Peaks at RT: 7.99 and 8.08 have 
the same retention time as the hydrogenated biosynthetic bisabolene (bisabolane geometric isomers). Peak at RT: 7.35 has the same retention time as 
hydrogenated commercial farnesene (farnesane). Peak at RT: 7.70 is partially hydrogenated bisabolene based on MS analysis of partial hydrogenation of 
biosynthetic bisabolene (  Supplementary Fig. S1  ). The ratio of bisabolane to farnesane is   ~  2.5:1.   
  Table  1       |     Fuel  properties  of  D2  diesel  fuel  and  biosynthetic 
alternatives. 
    Properties     D2  Diesel 
fuel   *   
  Biodiesel    †       Hydrogenated 
commercial 
bisabolene    ‡    
   Density  (g   ml     −     1 )   0.85   0.88   0.82 
   API  Gravity   35.0   29.3   41.1 
   Flash  point  ( ° C)   60 – 80   100 – 170   111 
   Kinetic  viscosity 
(mm  2    s      −     1 ) 
 1.3 – 4.1   4.0 – 6.0   2.91 
   Boiling  point  ( ° C)   180 – 340   315 – 350   267 
   Cloud  point  ( ° C)       −    35  to  5       −    3  to  15       <        −    78 
   Cetane  number   40 – 55   48 – 65   41.9 
    *      Biodiesel Handling and Use Guide, National Renewable Energy Laboratories  15 .   
    †         Biodiesel: Fatty acid methyl esters. Biodiesel Handling and Use Guide, National Renewable 
Energy Laboratories  15 .   
    ‡     Hydrogenated  commercial  bisabolene:  bisabolane:   ~ 50 % ,  farnesane:   ~ 20 % ,  partially 
hydrogenated  bisabolene:   ~ 20 % ,  and  aromatized  bisabolene:   ~ 7 %   ( Fig  3b ).   ARTICLE
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duction. However, curcumene was produced at only 130        μ g   l     −     1   in 
our   E. coli   FPP-overproducing platform. 
  Five of the six bisabolene synthases known in the literature at 
the beginning of the project produced bisabolene in        >       90  %   of their 
product profi  le  17  . Sequence alignment of the fi  ve bisabolene syn-
thases revealed two gene structures depending on their plant origin  18  
(  Fig. 4a  ). Angiosperm bisabolene synthases,   Arabidopsis thaliana  
(Z)-  γ  -bisabolene synthases TPS12 and TPS13 (ref.   19  ), have two 
domains, making them similar to previously characterized plant 
sesquiterpene synthases, such as amorphadiene synthase. Gymno-
sperm bisabolene synthases,   Pseudotsuga menziesii   (E)- γ -bisabo-
lene synthase TPS3 (ref.   20  ), and   Abies grandis   (E)- α -bisabolene 
synthase Ag1 (ref.     21), and   Picea abies   (E)- α -bisabolene  synthase 
TPS-BIS  22  , have three domains, making them structurally closer 
to diterpene synthases, such as abietadiene synthase, than to ses-
quiterpene synthases. Not knowing whether gene structure would 
infl  uence the microbial production of bisabolene, we screened both 
two- and three-domain bisabolene synthases. We synthesized the 
  E. coli   codon-optimized version of the two-domain bisabolene syn-
thases,   A. thaliana   TPS12 and TPS13. From other laboratories, we 
obtained the plant genes for two three-domain bisabolane synthases 
  P. menziesii   TPS3 and   A. grandis   Ag1. To test all fi  ve bisabolene syn-
thases that produce bisabolene in        >       90  %   of their product profi  le, we 
synthesized the   E. coli   codon-optimized version of the last three-
domain bisabolene synthase,   P. abies   TPS-BIS.   Figure 4b   shows the 
bisabolene production from each of the fi  ve bisabolene synthases. 
Among the two-domain bisabolene synthases,   A. thaliana   TPS13 
showed the highest bisabolene production at 35       ±    1 3    m g    l      −     1 ,  whereas 
  A. thaliana   TPS12 did not produce detectable levels of bisabolene. 
Among the three-domain bisabolene synthases,   P. abies   TPS-BIS 
did not produce detectable levels of bisabolene,   P. meziessi   TPS3 
produced bisabolene at 4        ±    2    m g    l      −     1   and   A. grandis   Ag1 produced 
78    ±    1 4    m g    l      −     1   of bisabolene. To further increase bisabolene pro-
duction, we synthesized the   E. coli   codon-optimized version of the 
highest bisabolene-producing gene,   A. grandis   Ag1, to generate 
AgBIS. As shown in   Figure 4b  , AgBIS increased bisabolene produc-
tion fi  vefold to 389       ±    4 9    m g    l      −     1  . AgBIS produced   α -bisabolene  as  a 
single product (  Supplementary Fig. S2  ). Th   e increase in microbial 
bisabolene production seen with AgBIS when compared with that 
of Ag1 can be attributed to an increase in soluble expression of the 
bisabolene synthase enzyme in   E. coli   ( Supplementary  Fig.  S3 ).   
  Metabolic engineering doubles bisabolene titers in   E. coli     .     Wi t h  
the highest bisabolene-producing gene in hand (AgBIS), we set out to 
improve the   E. coli   production of FPP via metabolic engineering of the 
mevalonate pathway ( Fig. 5 ). For optimization, we conceptually divided 
the mevalonate pathway into a top portion that converts acetyl-CoA 
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    Figure  4     |          Screening  bisabolene  synthases  for  high  bisabolene  titers 
in   E. coli  . (  a  ) Gene structure of bisabolene synthases screened. (  b )   E. coli  
bisabolene production as a function of bisabolene synthase using 
pJBEI-2704 as the heterologous mevalonate pathway. The experiments 
were carried out in triplicate. Shown is the mean bisabolene production 
after 73     h of growth in EZ-rich deﬁ  ned medium with 1  %   glucose. The error 
bars represent the standard deviation from the mean. CO, gene synthesized 
using   E. coli   codon usage. Plant, original plant gene.   
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  Figure  5     |          Improving   E. coli  bisabolene titers via metabolic engineering 
of the mevalonate pathway. (  a  ) The mevalonate pathway converts acetyl-
CoA into FPP in eight enzymatic steps: acetyl-CoA acetyltransferase (  atoB ), 
truncated HMG-CoA reductase (  tHMGR  ), HMG-CoA synthase (  HMGS ), 
mevalonate kinase (  MK  ), phosphomevalonate kinase (  PMK ),  mevalonate 
diphosphate decarboxylase (  PMD  ), isoprenyl diphosphate isomerase 
(  idi  ) and farnesyl diphosphate synthase (  ispA  ). Gene names in uppercase 
are original genes from   S. cerevisiae  , and gene names in lowercase are 
endogenous   E. coli   genes. Gene names in red have been synthesized to 
match   E. coli   codon usage. (  b)    E. coli   bisabolene production as a function 
of the mevalonate pathway using AgBIS as the bisabolene synthase. The 
experiments were carried out in triplicate. Shown is the mean bisabolene 
production after 73     h of growth in EZ-rich deﬁ  ned media with 1  %   glucose. 
The error bars represent the standard deviation from the mean.   ARTICLE   
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into mevalonate and a bottom portion that converts mevalonate 
into FPP. Th   e mevalonate pathway is heterologous to   E. coli  , and the 
genes encoding truncated HMG-CoA reductase (  tHMGR ),  HMG-
CoA synthase (  HMGS  ), mevalonate kinase (  MK ),  phosphomeval-
onate kinase (  PMK  ), and mevalonate diphosphate decarboxylase 
(  PMD  ) are derived from   S. cerevisiae  8 .  Th  e    E. coli   strain  harbouring 
AgBIS with our original heterologous mevalonate pathway (pJBEI-
2704) produced 388       ±    4 9    m g    l      −     1   bisabolene. In the fi  rst optimization 
attempt, we codon-optimized four of the fi  ve   S. cerevisiae   genes 
present in the mevalonate pathway ( tHMGR ,  HMGS ,  MK , and  PMK ) 
to match the  E. coli  codon usage to generate pJBEI-2997. We did not 
codon-optimize PMD, as previous proteomic studies showed high 
protein levels of PMD  12 .  Th   is platform produced 586       ±    6 5    m g    l      −     1   bis-
abolene. To improve expression of the enzymes in the bottom por-
tion of the pathway, we placed these genes under control of a second 
promoter (P  trc ) (pJBEI-2999). Th   is platform produced 912    ±    4 3    m g    l      −     1  
of bisabolene, which is a twofold improvement in bisabolene pro-
duction over our original platform. On the basis of the mevalonate 
pathway-dependent theoretical yield of 0.25      g sesquiterpene per g 
of glucose  5  , and assuming that only glucose is being converted to 
bisabolene, we have reached 36  %   of apparent theoretical yield using 
defi  ned rich media with 1  %   glucose. To determine the actual yield 
and the percentage of theoretical yield for bisabolene production in 
  E. coli  , we used the highest   E. coli   bisabolene production strain, that 
is,   E. coli   harbouring JBEI-2999 and AgBIS, and repeated the shake 
fl  ask production in minimal medium. Th   e actual yield of bisabolene 
production  is  0.01   g   g     −     1   of  glucose  ( ~ 208   mg   l     −     1   aft   er  72   h  with  2 %  
glucose). Th   erefore, our   E. coli   platform is at 4  %   of theoretical yield. 
Th   e lower yield in minimal medium suggests that more optimiza-
tion is needed for the use of these strains in minimal medium.     
  Engineering bisabolene production in  S. cerevisiae     .    In  addition  to 
production in   E. coli  , we also engineered bisabolene production in 
  S. cerevisiae  , a host widely used for production of ethanol (  Fig. 6  ). 
Specifi  cally, we adapted a previously engineered   S. cerevisiae   FPP 
overproduction platform for the production of bisabolene. Briefl  y, 
in the   S. cerevisiae   FPP overproduction platform, the truncated 
HMG-CoA reductase (  tHMGR  ), the FPP synthase (  Erg20  ), and the 
global transcription regulator of the sterol pathway   upc2-1   were 
overexpressed and the squalene synthase (  Erg9 )  was  downregulated 
from the chromosome  9  . We adapted this yeast platform for the pro-
duction of bisabolene by placing the bisabolene synthases under 
control of the galactose promoter on a high-copy plasmid (2      μ )  con-
taining the auxotrophic Leu2d marker previously used to achieve 
the highest production of amorphadiene  11  . Given that   in vivo  
enzymatic activity is sometimes context (organism) dependent  9,23 , 
we screened the same bisabolene synthases previously screened in 
  E. coli   in   S. cerevisiae  .   Figure 6b   shows the bisabolene production 
from each of the fi  ve bisabolene synthases in   S. cerevisiae .  Neither 
of the two-domain bisabolene synthases,   A. thaliana   TPS12  or 
TPS13, showed detectable levels of bisabolene. Unlike in   E. coli , 
all three-domain sesquiterpene synthases produced bisabolene in 
  S. cerevisiae .   P. abies   TPS-BIS  produced  23    ±    7    m g    l      −     1   bisabolene, 
  P. meziessi   TPS3  produced  69    ±    7    m g    l      −     1   bisabolene, and   A. grandis  
Ag1 produced 66        ±    1 1    m g    l      −     1  . Interestingly, the bisabolene pro-
ductions of   P. meziessi   TPS3 and   A. grandis   Ag1 are much closer 
together in   S. cerevisiae   than in   E. coli .  Th   e highest production was 
achieved using AgBIS at 994       ±    241   mg   l     −     1 .   
  Bisabolene shows low toxicity to   E. coli   and   S. cerevisiae     .    In  addi-
tion to high microbial titers, the feasibility of bisabolene as a biofuel 
precursor will depend on the toxicity it imparts to the overproducing 
organism.   Figure 7   shows that commercial bisabolene imparts low to 
no toxicity to   E. coli   and   S. cerevisiae   when added exogenously to the 
medium. Th  e   E. coli   and   S. cerevisiae   cell growth are comparable at 
0  %   (v  /  v) bisabolene and up to 20  %   (v  /  v) of exogenously added bisabo-
lene. Above 20  %   (v  /  v) of exogenously added bisabolene, bisabolene 
phase-separated from the culture medium. Th   e lack of toxicity to the 
tested microbial platforms should enable the production of bisabolene 
in high titers.     
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   Figure  6     |          Screening  bisabolene  synthases  for  high  bisabolene  titers 
in   S. cerevisiae . (  a )   S. cerevisiae   strain previously engineered for the 
production of amorphadiene  9   (EPY300) was re-engineered to produce 
bisabolene by overexpressing bisabolene synthase. In   S. cerevisiae , 
acetyl-CoA acetyltransferase is   Erg10  , isoprenyl diphosphate isomerase 
is   IDI1  , and farnesyl disphosphate synthase is   Erg20  . Gene names in 
blue (  upc2-1 ,   tHMGR ,   ERG20   and   BIS  ) are overexpressed. (  b )   S. cerevisiae   
(EPY300) bisabolene production as a function of bisabolene synthase. 
The experiments were carried out in triplicate. Shown is the mean 
bisabolene production after 96     h of growth in rich medium (YEP) with 1.8  %   
galactose  /  0.2  %   glucose. The error bars represent the standard deviation 
from the mean. CO, gene synthesized using   E. coli   codon usage. Plant, 
original plant gene.   
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  Figure  7     |          Toxicity  of  commercial  bisabolene  to   E. coli   and   S. cerevisiae . 
(  a )   E. coli   growth after 24     h in the presence of 0  –  20  %   (v  /  v) of commercial 
bisabolene. (  b )   S. cerevisiae   growth after 16     h in the presence of 0  –  20  %   v  /  v 
of commercial bisabolene. The experiments were carried out in triplicate. 
Shown is the mean growth after overnight growth and the error bars 
represent the standard deviation from the mean.   ARTICLE
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  Chemical hydrogenation of biosynthetic bisabolene   .    To  demon-
strate that microbially produced bisabolene can be converted to the 
biosynthetic D2 diesel alternative, bisabolane, we used a palladium 
on carbon catalyst to chemically reduce biosynthetic bisabolene into 
fully hydrogenated bisabolanes (  Fig. 8  ). First, we isolated biosyn-
thetic bisabolene from   E. coli   cell cultures and we assigned its NMR 
spectra  ( Supplementary  Figs  S4 – 6 ).  Th   en, we fully reduced the bio-
synthetic bisabolene into a 3:1 mixture of bisabolanes. Bisabolene 
was fully hydrogenated to bisabolane as demonstrated by the lack of 
vinylic protons in the   1      H NMR spectrum (  Supplementary Fig. S7  ) 
and the lack of alkenes and   13  C NMR (  Supplementary Fig. S8  ) spec-
trum. On the basis of the chemical structure of  α -bisabolene and the 
reaction mechanism of Pd-catalyzed hydrogenation, we infer that 
the bisabolanes are geometric isomers (  Supplementary Fig. S9  ).       
 Discussion 
  Here we present a framework for the rapid identifi  cation  and 
development of a terpene-based advanced biofuels that sets prec-
edent for the discovery of other advanced biofuels. In the absence 
of a commercial source of bisabolane, chemical hydrogenation of 
commercial bisabolene led to the identifi  cation of bisabolane as a 
biosynthetic alternative to D2 diesel. Th  e  fl  exibility of the   E. coli   and 
  S. cerevisiae   FPP-overproducing platforms allowed us to rapidly 
switch from the overproduction of amorphadiene to that of bisabo-
lene, the immediate precursor to bisabolane. In   E. coli ,  bisabolene 
synthase screening and codon-optimization followed by metabolic 
engineering of the heterologous mevalonate pathway led to a ten-
fold increase in bisabolene titers. In   S. cerevisiae  , screening of the 
bisabolene  synthases  led  to  bisabolene  titers      >    900   mg   l     −     1  , the high-
est sesquiterpene titer in this organism to date. Further, we showed 
that bisabolene toxicity is not a limit in the microbial production 
of bisabolene in either   S. cerevisiae   or   E. coli .  Finally,  we  demon-
strated chemical conversion of biosynthetic bisabolene into bis-
abolane using chemical hydrogenation. To our knowledge, this is 
the fi  rst report of a reduced monocyclic sesquiterpene, bisabolane, 
as a biosynthetic alternative to D2 diesel, and the fi  rst microbial 
overproduction  of  bisabolene  at      >    900   mg   l     −     1 . 
  It is currently diffi   cult to obtain large quantities of biosynthetic 
bisabolene to hydrogenate and test its fuel properties. Th  e shake 
fl  ask production experiments reported in this manuscript have been 
performed with an organic overlay for analysis purposes. Although 
both the   E. coli   and   S. cerevisiae   strains produce high levels of the 
sesquiterpene, purifi   cation of bisabolene is currently challeng-
ing due to co-evaporation of the product and the organic overlay. 
Further improvements in bisabolene production or an alternative 
separation technology will be required to obtain the quantities of 
highly pure bisabolene needed for fuel properties testing. Th  rough 
multiple rounds of large-scale preparation in shake fl  asks, we have 
prepared   ~  20      ml of biosynthetic bisabolene, hydrogenated it, and 
performed preliminary fuel properties testing. Th   ough the results 
are preliminary due to an insuffi   cient sample amount for com-
plete testing, the preliminary cetane number of the hydrogenated 
biosynthetic bisabolene is 52.6. Once the complete fuel properties 
of hydrogenated biosynthetic bisabolene can be obtained, we will 
be able to estimate the impact of byproducts present in the hydro-
genated commercial bisabolene, such as farnesane and aromatized 
bisabolene (  Fig. 3b  ). Given the similar ratios of potentially benefi  -
cial (farnesane) and detrimental (aromatized and partially reduced 
bisabolenes) byproducts in the hydrogenated commercial bisabo-
lene, we estimate that the measured physicochemical properties 
reported in this work can be largely attributed to the major product, 
bisabolane. 
  While bisabolane has physicochemical properties similar to D2 
diesel, it must be produced at high yields from the sugar source using 
a relatively simple process to be economically viable. Here we pro-
duced bisabolene in   E. coli   at   ~ 36 %   of  apparent  pathway-dependent 
theoretical yield, and at 4  %   of pathway-dependent theoretical yield 
in minimal medium. We are currently optimizing the fermentation 
conditions, pathway genes and the organism to improve the produc-
tivity in minimal medium and also to produce larger quantities of 
biosynthetic bisabolene for complete fuel property analysis. Further, 
the low toxicity of bisabolene to  E. coli  and  S. cerevisiae  should allow 
production of bisabolene at very high titers. 
  An economic analysis on the production of bisabolene takes into 
consideration many variables including the cost and type of feed-
stock, biomass depolymerization method, and the microbial yield 
of biofuel. Assuming a break-even price of sugar at the mill to be 
close to US   $  0.10  /  lb, which is lower than the current volatile spot 
price but closer to the long-term nominal price of the commod-
ity, we can perform a rough calculation of the theoretical cost of 
bisabolene. On the basis of that number, the raw material cost of 
bisabolene production would be, ignoring non-sugar costs, approxi-
mately   $  0.88 per kg of bisabolene. Assuming raw material costs to 
be  only   ~ 50 %   of  the  fi  nal cost, this would imply a fi  nal cost of   $  1.76 
per kg, or   $  5.73 per gal of bisabolene on the basis of data for etha-
nol production  24  . (We assumed the raw material cost for bisabolene 
as 50% of total cost which is lower than that of ethanol (66%) on 
the assumption that the bisabolene production process will be more 
involved and, thus, more costly than the production of ethanol). At 
an estimated   ~    $  6 per gal, bisabolene is currently more expensive 
than current D2 diesel. However, it is still promising to investigate 
this emerging alternative biofuel when considering its superior 
properties and renewable nature. 
  Finally, in this work we have resorted to chemical hydrogenation 
of bisabolene into the fi  nal product bisabolane. While industrially 
feasible, the ultimate goal is the complete microbial production of 
bisabolane. Th   is will require the reduction of terpenes   in vivo   using 
designer reductases and, potentially, balancing cellular reducing 
equivalents.   
 Methods  
  Hydrogenation of commercial bisabolene   .     Bisabolene   (mixture  of  isomers)  was 
purchased from   TCI America   (catalogue No. B1413).   10  %   Pd  /  C   was purchased 
from   Aldrich   (catalogue No. 205699). 25     ml of bisabolene was added in Parr high-
pressure reaction vessel with 125 ml glass insert. 250     mg of 10  %   Pd  /  C (10 wt   %   of 
substrate) was added and the reaction vessel was fl  ushed with hydrogen several 
times at 500     psi. Th   e reaction mixture was pressurized with hydrogen to 1,200     psi 
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  Figure  8     |          Chemical  hydrogenation  of  biosynthetic  bisabolene  ( 1 )  into 
biosynthetic bisabolane (  2  ). Gas chromatogram trace of biosynthetic 
bisabolene (RT: 8.90) and fully hydrogenated biosynthetic bisabolene. 
Hydrogenation of biosynthetic bisabolene leads to a mixture of two 
geometric bisabolane isomers (RT: 7.99 and 8.08) in a 3:1 ratio.   ARTICLE   
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and  stirred  at  25    ° C.  Th   e reaction vessel was repressurized to 1,200     psi when the 
pressure dropped below 100     psi and stirred until no further decrease of hydrogen 
pressure was observed. Th   e excess hydrogen was removed and the mixture was 
fi  ltered over celite. Th  e  fi  ltrate was dried under high vacuum overnight, and the 
product was directly used for fuel property test without any further purifi  cation.     
  Cetane number of hydrogenated commercial bisabolene   .     Th  e  cetane  number 
measurements were executed by Dr. Matthew Ratcliff   at NREL. Th   e ignition delay 
of the bisabolene sample or the hydrogenated bisabolene sample (  ~  60     ml) was 
measured with the Ignition quality tester (IQT), using ASTM D6890-08 and con-
verted to derived cetane number. Further ignition delay measurements were made 
to determine the sensitivity of hydrogenated bisabolene to combustion tempera-
ture, pressure and oxygen concentration. Th   e data were regressed on a modifi  ed 
Arrhenius plot to determine the apparent activation energy (Ea) and the oxygen 
mole fraction dependency (b).     
  Properties of hydrogenated commercial bisabolene   .     Th   e properties were 
measured at the Southwest Research Institute (San Antonio, Texas). Th  e  following 
ASTM methods were used for each property measurement: cloud point measure-
ment (ASTM D5773), specifi  c gravity or density measurement (ASTM D4052), 
fl  ash point measurement (ASTM D93), kinetic viscosity measurement (ASTM 
D445), and boiling point (ASTM D2887).     
  Bisabolene synthase vectors   .    For  bisabolene  production  in   E. coli ,  the  fi  ve 
bisabolene synthase genes were cloned into vector pTrc99 between NcoI and XmaI 
sites. Th   e genes were amplifi  ed from their respective templates using their respec-
tive primers, digested with NcoI and XmaI and cloned into pTrc99. For bisabolene 
production in   S. cerevisiae ,  the  fi  ve bisabolene synthase genes were cloned into the 
vector pRSLeu2d  11   between   Nhe  I and   Xho  I sites. Th   e genes were amplifi  ed from 
their respective templates using their respective primers, digested with   Nhe I  and 
  Xho  I, and cloned into pRSLeu2d.     
  Mevalonate pathway vectors      .     pBb plasmids were prepared as the BglBrick 
standard expression vectors  25 .  Th   e top portion of the mevalonate pathway contains 
genes for the conversion of acetyl CoA to mevalonate: acetoacetyl-CoA synthase 
from   E. coli   ( atoB  ), HMG-CoA synthase from   S. cerevisiae   ( HMGS  ), and an amino-
terminal truncated version of HMG-CoA reductase from   S. cerevisiae   ( HMGR ). 
Th   e bottom portion of the mevalonate pathway contains genes for the conversion 
of mevalonate toFPP: mevalonate kinase from   S. cerevisiae   ( MK ),  phosphomeval-
onate kinase from   S. cerevisiae   ( PMK  ), phosphomevalonate decarboxylase from 
  S. cerevisiae   ( PMD  ), IPP isomerase from   E. coli   ( idi  ), and farnesyl diphosphate 
synthase from   E. coli   ( ispA  ). pJBEI-2704 (pBbA5c-MevT-MBIS): Th  e  construction 
of this plasmids has been previously reported  12 .  pJBEI-2997  (pBbA5c-MevT(CO)-
MBIS(CO)): pBbA5c-MevT(CO) was constructed by ligating pBbA5c vector 
(  Bam HI /  Xho  I) and BglBrick compatible codon optimized HMGS and HMGR 
inserts (  Bg lII /  Xho  I), using BglBrick cloning strategy with compatible   Bg  lII and   Bam HI 
restriction. Individual genes were PCR-amplifi  ed from pAM45 (ref.     16) with 
primers contain   Eco  RI and   Bgl  II sites at 5  ′  -end and   Bam  HI and   Xho  I sites at 3  ′ -end 
of each gene. Th   e BglBrick restriction sites found in each gene were removed by 
site-specifi  c mutagenesis. pBbA5c-MevT(CO)-MBIS(CO) was prepared by the 
ligation of pBbA5c-MevT(CO) vector (  Bam HI /  Xho  I) and MBIS with   E. coli   codon 
optimized MK and PMK insert (  Bg lII /  Xho  I). pJBEI-2999 (pBbA5c-MevT(CO)-P  trc -
MBIS(CO)): Th   e plasmid was prepared by two-step ligation of pBbA5c-MevT(CO) 
vector (  Bam HI /  Xho  I) and a double terminator-Ptrc gene part (  Bg lII /  Xho I)  and 
MBIS(CO) insert (  Bg lII /  Xho  I) by standard BglBrick cloning strategy.     
  Bisabolene production in   E. coli     .     For the bisabolene synthase screen,   E. coli   DH1 
was co-transformed with pJBEI-2704 and either pJBEI-3175 (TPS12), pJBEI-3167 
(TPS13), pJBEI-3177 (TPS-BIS), pJBEI-3604 (TPS3), pJBEI-3360 (Ag1), or 
pJBEI-3361 (AgBIS). For the optimization of the mevalonate pathway,   E. coli   DH1 
was co-transformed with AgBIS and any one of pJBEI-2704, pJBEI-2997, and pJBEI-
2999. Pre-cultures of   E. coli   DH1 harbouring the appropriate plasmids were used to 
inoculate at a 1:100 dilution bisabolene production media (  Teknova  ,   EZ-Rich  , 1  %   
(v / v)  glucose,  amp 100 ,  cm 30 ,  50   ml).  Th   e cultures were grown at 37       °  C for 5.5     h (180     r.
p.m., OD  600     =    0.6 – 0.8)  before  induction  with  500    μ  M IPTG and overlayed with 20  %   
dodecane. Aft  er growth for 73     h at 30       °  C (180     r.p.m.), 10       μ  L of the dodecane overlay 
were sampled and diluted into 990       μ  l of ethyl acetate spiked with caryophyllene as an 
internal standard. Th   e samples were analysed by GC  /  MS (Th   ermo Trace Ultra with 
PolarisQ  MS)  with  a  TR-5MS  column  (30   m × 0.25   mm  ID   × 0.25    μ m  fi  lm) using a 
cadinene standard curve using the following conditions: inlet at 225       °  C, 1.2     ml     min      −     1  
constant fl  ow, transfer line at 300       °  C, ion source at 200       °  C, scan   m  /   z   50 – 300.  Oven: 
60    ° C  for  1   min,  ramp  at  25    ° C   min     −     1   to 220       °  C, hold 2     min. For actual yield calcula-
tions, we used minimal medium with glucose as the only carbon source. Bisabolene 
production was executed as described above with   E. coli   DH1 harbouring JBEI-2999 
and pJBEI-3361 in minimal medium (M9 medium supplemented with trace ele-
ments,  2 %   (v / v)  glucose,  amp 100 ,  cm 30 ,  50   ml).  Aft  er 72     h of growth the dodecane 
layer was sampled and analysed by GC  /  FID (Th   ermo Focus with FID) equipped with 
a  DB-5HT  column  (10   m × 0.32   mm  ID   × 0.1    μ m  fi  lm), using a caryophyllene standard 
curve using the following conditions: inlet at 250       °  C, FID at 320       °  C, 100     kPa constant 
pressure;  oven:  60    ° C  for  0.75   min,  40    ° C   min     −     1   to 200       °  C. Glucose was measured via 
high-pressure liquid chromatography (HPLC) before and during bisabolene produc-
tion. Glucose was completely consumed aft   er  24   h.   
  Bisabolene production in   S. cerevisiae     .     Pre-cultures of   S. cerevisiae   strain  EPY300 
(ref.     9) transformed with the appropriate plasmid for bisabolene synthase expression 
was used to inoculate at an OD  600   of 0.05 into 5     ml of YEP supplemented with 1.8  %   
galactose / 0.2 %   glucose  and  overlayed  with  10 %   dodecane.  Aft  er 96     h of growth 
at  30    ° C,  10    μ  L of the dodecane layer were sampled and diluted into 990       μ l  of 
ethyl acetate spiked with caryophyllene as an internal standard. Th   e samples were 
analysed  by  GC / FID  (Th   ermo Focus with FID) equipped with a DB-5HT column 
(10   m × 0.32   mm  ID   × 0.1    μ m  fi  lm) using a caryophyllene standard curve using the 
following conditions: inlet at 250       °  C, FID at 320       °  C, 100     kPa constant pressure; 
oven:  60    ° C  for  0.75   min,  ramp  40    ° C   min     −     1   to  200    ° C.   
  Bisabolene microbial toxicity   .     To    E. coli  : an overnight culture of   E. coli   DH1 
harbouring AgBIS and JBEI-2999 was used to inoculate 1     ml cultures containing 
0 – 20 %   (v / v)  of  commercial   bisabolene   ( TCI  America    B1413 )  at  an  OD 600     =    0.05 
in triplicate. Th   e cultures were grown for at 37       °  C for 24     h before the OD  600   was 
measured. To   S. cerevisiae  : an overnight culture of EPY300 (SD-HIS-MET, 2  %   
glucose) was used to inoculate 1     ml cultures containing 0  –  20  %   (v  /  v) of commercial 
bisabolene at an OD  600     =    0.05  in  triplicate.  Th   e cultures were grown for at 30       °  C for 
16   h  before  the  OD 600   was  measured.   
  Puriﬁ  cation of biosynthetic bisabolene   .     Th  e    E. coli   or   S. cerevisiae   bisabolene 
production strains were grown as previously described but overlayed with decane, 
instead of dodecane, to facilitate bisabolene extraction. Th   e decane overlay was 
separated from the culture medium using a separatory funnel and dried over so-
dium sulfate. Th   e decane was evaporated under reduced pressure, and the left  over 
oil was loaded onto a silica gel column for column chromatography using hexanes 
as the solvent. Th   e product containing fractions were pooled and the solvent was 
evaporated under reduced pressure. Th   e product was obtained as colourless oil.     
  Chemical hydrogenation of biosynthetic bisabolene   .     Th   e biosynthesized bisabo-
lene in dodecane overlay or in hexane for purifi   ed  bisabolene  (60   ml,  1.52   mmol.  of 
bisabolene) was dried under high vacuum overnight and was added into Parr high-
pressure reaction vessel with 125-ml glass insert. 100     mg of 10  %   Pd  /  C was added 
and the reaction vessel was fl  ushed with hydrogen several times at 500     psi. Th  e 
reaction mixture was pressurized with hydrogen to 1,200     psi and stirred at 25       °  C 
overnight. Th   e excess hydrogen was removed and the mixture was fi  ltered over 
celite. Th  e  fi  ltrate was dried under high vacuum, and the product was analysed by 
GC  /  MS without any further purifi  cation. Th   e reaction mixture in hexane was also 
fi   ltered  over  celite,  and  the  solvent  was  removed  under  reduced  pressure.                        
   References  
   1   .      United  Nations  Environment  Programme ,      .    Towards  sustainable  production 
and  use  of  resources  -  assessing  biofuels      (    www.unep.fr  ;        http://www.uneptie.
org/energy/bioenergy/documents/pdf/Assessing%20Biofuels-Summary-
Web-.pdf    )    (  2009  ).  
    2   .       Peralta-Yahya  ,    P .   P .       &      Keasling  ,    J .   D .         Advanced  biofuel  production  in  microbes  . 
  Biotechnol. J.      5   ,     147   –   162    (  2010  ).  
   3    .        F o r t m a n   ,     J .    L  .          et al.        Biofuel  alternatives  to  ethanol:  pumping  the  microbial  well  . 
  Trends Biotechnol.      26   ,     375   –   381    (  2008  ).  
   4   .       Kirby  ,    J .       &      Keasling  ,    J .   D .         Biosynthesis  of  plant  isoprenoids:  perspectives  for 
microbial  engineering  .    Annu. Rev. Plant Biol.      60   ,     335   –   355    (  2009  ).  
    5   .       Rude  ,    M .       &      Schirmer  ,    A .         New  microbial  fuels:  a  biotech  perspective  .    Curr. 
Opin. Microbiol.      12   ,     274   –   281    (  2009  ).  
  6   .       Harvey  ,    B .   G .    ,     Wright  ,    M .   E .       &      Quintana  ,    R .   L .         High-density  renewable  fuels 
based on the selective dimerization of pinenes    .     Energ. Fuel.      24   ,     267   –   273    (  2010  ).  
   7   .       Renniger  ,    N .       &      McPhee  ,    D .         Fuel  compositions  comprising  farnesane  and 
farnesane derivatives and method of making and using same    .     U.S. Patent No  .  
7399323    (  2008  ).  
       8    .        M a r t i n   ,     V .    J .     ,      P i t e r a   ,     D .    J .     ,      Wi t h e r s   ,     S  .    T .     ,      N e w m a n   ,     J .    D .        &       K e a s l i n g   ,     J .    D .       
    Engineering a mevalonate pathway in   Escherichia coli   for production of 
terpenoids  .    Nat. Biotechnol.      21   ,     796   –   802    (  2003  ).  
      9    .        R o  ,     D .    K  .          et al.        Production  of  the  antimalarial  drug  precursor  artemisinic  acid 
in  engineered  yeast  .    Nature      440   ,     940   –   943    (  2006  ).  
  10   .       Yoshikuni  ,    Y .    ,     Ferrin  ,    T .   E .       &      Keasling  ,    J .   D .         Designed  divergent  evolution of 
enzyme  function  .    Nature      440   ,     1078   –   1082    (  2006  ).  
     1 1    .        R o  ,     D .    K  .          et al.             Induction of multiple pleiotropic drug resistance genes in yeast 
engineered to produce an increased level of anti-malarial drug precursor, 
artemisinic  acid  .    BMC Biotechnol.      8   ,     83    (  2008  ).  
      12   .       Redding-Johanson  ,    A .   M .         et al.        Targeted  proteomics  for  metabolic  pathway 
optimization: Application to terpene production    .     Metab. Eng.      13   ,     194   –   203   
(  2011  ).  
   1 3    .        Ts u r u t a   ,     H  .          et al.        High-level  production  of  amorpha-4,11-diene,  a  precursor 
of the antimalarial agent artemisinin, in   Escherichia coli   .     PLoS One      4   ,     e4489   
(  2009  ).  ARTICLE
8 
NATURE  COMMUNICATIONS   |     DOI:   10.1038/ncomms1494 
NATURE COMMUNICATIONS   |   2:483   |     DOI:   10.1038/ncomms1494    |   www.nature.com/naturecommunications
© 2011 Macmillan Publishers Limited. All rights reserved.
   1 4    .        L e e   ,     S  .    K  .     ,      C h o u   ,     H  .     ,      H a m   ,     T .    S  .     ,      L e e   ,     T .    S  .        &       K e a s l i n g   ,    J .   D .         Metabolic 
engineering of microorganisms for biofuels production: from bugs to synthetic 
biology  to  fuels  .    Curr. Opin. Biotechnol.      19   ,     556   –   563    (  2008  ).  
      15   .      National  Renewable  Energy  Laboratory     .    Biodiesel  handling  and  use  guide 
(Fourth  Edition)      (    www.nrel.gov  ;        http://www.nrel.gov/vehiclesandfuels/
pdfs/43672.pdf    )      (  2009  ).  
    1 6    .        A n t h o n y  ,     J .    R  .     ,      A n t h o n y  ,     L  .    C  .     ,      N o w r o o z i   ,     F .     ,      Kw o n   ,     G  .     ,      N e w m a n   ,     J .    D .        &   
   Keasling  ,    J .   D .         Optimization  of  the  mevalonate-based  isoprenoid  biosynthetic 
pathway in   Escherichia coli   for production of the anti-malarial drug precursor 
amorpha-4,11-diene  .    Metab. Eng.      11   ,     13   –   19    (  2009  ).  
     17   .       Degenhardt  ,    J .    ,     Kollner  ,    T .   G .       &      Gershenzon  ,    J .         Monoterpene  and  sesquiterpene 
synthases and the origin of terpene skeletal diversity in plants    .     Phytochemistry   
  70   ,     1621   –   1637    (  2009  ).  
   18   .       Trapp  ,    S .   C .       &      Croteau  ,    R .   B .         Genomic  organization  of  plant  terpene 
synthases and molecular evolutionary implications    .     Genetics      158   ,     811   –   832   
(  2001  ).  
   1 9    .        R o  ,     D .    K  .     ,      E h l t i n g   ,     J .     ,      K e e l i n g   ,     C  .    I  .     ,      L i n   ,     R  .     ,      M a t t h e u s   ,     N  .        &       B o h l m a n n   ,     J .       
  Microarray  expression  profi  ling and functional characterization of AtTPS 
genes: Duplicated   Arabidopsis thaliana   sesquiterpene synthase genes 
At4g13280 and At4g13300 encode root-specifi  c and wound-inducible (Z)-
gamma-bisabolene  synthases  .    Arch. Biochem. Biophys.      448   ,     104   –   116   
(  2006  ).  
   2 0    .        Hu b e r  ,     D .    P .     ,      P h i l i p p e   ,     R  .    N  .     ,      G o d a r d   ,     K  .    A  .     ,      S t u r r o c k   ,     R  .    N  .        &       B o h l m a n n   ,     J .       
    Characterization of four terpene synthase cDNAs from methyl jasmonate-
induced Douglas-fi  r,   Pseudotsuga menziesii   .     Phytochemistry      66   ,     1427   –   1439   
(  2005  ).  
   2 1    .        B o h l m a n n   ,     J .     ,      C r o c k   ,     J .     ,      J e t t e r  ,     R  .        &       C r o t e a u   ,     R  .          Te r p e n o i d - b a sed defenses in 
conifers: cDNA cloning, characterization, and functional expression of wound-
inducible (E)-alpha-bisabolene synthase from grand fi  r (  Abies grandis )  .    Proc. 
Natl Acad. Sci. USA      95   ,     6756   –   6761    (  1998  ).  
   22   .       Martin  ,    D .   M .    ,     F ä ldt  ,    J .       &      Bohlmann  ,    J .         Functional  characterization  of nine 
Norway spruce TPS genes and evolution of gymnosperm terpene synthases of 
the TPS-d subfamily    .     Plant Physiol.      135   ,     1908   –   1927    (  2004  ).  
  2 3    .        C h a n g   ,     M  .    C  .     ,      E a c h u s   ,     R  .    A  .     ,      Tr i e u   ,     W .     ,      R o  ,     D. -   K  .        &       K e a s l i ng  ,    J .   D .         Engineering 
  Escherichia coli   for production of functionalized terpenoids using plant P450s    . 
  Nat. Chem. Biol.      3   ,     274   –   277    (  2007  ).  
   24   .       Von  Lampe  ,    P .         Agricultural  market  impacts  of  future  growth  in  the  production 
of  biofuels.  Organization  for  Economic  Co-operation  and  Development      (    www.
oecd.org  ;        www.oecd.org/dataoecd/58/62/36074135.pdf    )    (  2006  ).    
   2 5    .        A n d e r s o n   ,     J .    C  .          et al.        BglBricks:  A  fl  exible standard for biological part assembly    . 
  J. Biol. Eng.      4   ,     1    (  2010  ).    
           Acknowledgements  
 Th   is work was part of the DOE Joint BioEnergy Institute (  http://www.jbei.org  ) 
supported by the US Department of Energy, Offi   ce of Science, Offi   ce of Biological and 
Environmental Research, through contract DE-AC02-05CH11231 between Lawrence 
Berkeley National Laboratory and the US Department of Energy. We thank Prof. Rodney 
Croteau at Washington State University for the   Abies grandis   bisabolene synthase 
gene (pSBAg1), Prof. J  ö  rg Bohlmann at Th   e University of British Columbia for the 
  Pseudotsuga menziesii   bisabolene synthase gene (pPmeTPS3), Dr Matthew Ratcliff   at the 
National Renewable Energy Laboratory (NREL) for the cetane number measurement, 
and Dr Daniel Klein-Marcuschamer at JBEI for economic analysis.     
    Author  contributions  
  P.P.-Y., M.O., A.M., J.D.K. and T.S.L. designed the experiments. P.P.-Y., T.S.L., M.O. and 
R.C. performed the experiments. P.P.-Y., T.S.L. and J.D.K. wrote the manuscript. 
  Additional  information  
  Supplementary Information accompanies this paper at   http://www.nature.com/
naturecommunications  
  Competing fi  nancial interests:   JDK has fi  nancial interest in Amyris Biotechnologies and 
LS9 Inc. Th   e remaining authors declare no competing fi  nancial interest. 
  Reprints and permission   information is available online at   http://npg.nature.com/
reprintsandpermissions/  
  How to cite this article:   Peralta-Yahya, P. P.   et al.   Identifi  cation and microbial production 
of a terpene-based advanced biofuel.   Nat. Commun.   2:483 doi: 10.1038  /  ncomms1494 (2011).     
   License:      Th   is work is licensed under a Creative Commons Attribution-NonCommercial-
Share Alike 3.0 Unported License. To view a copy of this license, visit http://
creativecommons.org/licenses/by-nc-sa/3.0/       